Ex vivo expanded hematopoietic stem cells retain high levels of primitive progenitor stem cells with myeloid (LTC-IC) and lymphoid (NK&B) potential.

被引：0
|
作者：
Douay, L
Giarratana, MC
Kobari, L
Vergé, V
Neildez, TA
Barret, C
Gorin, NC
机构：
[1] Hop Trousseau, Serv Hematol Biol, F-75571 Paris, France
[2] Hop St Antoine, INSERM U417, F-75571 Paris, France
来源：
EXPERIMENTAL HEMATOLOGY | 1999年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
322
引用
收藏
页码：122 / 122
页数：1
相关论文
共 46 条
  • [21] DECLINED PRESENTATION MEGAKARYOCYTE PROGENITORS CAPABLE OF PRODUCING FUNCTIONAL PLATELETS CAN BE EXPANDED EX VIVO FROM CD34+HEMATOPOIETIC STEM/PROGENITOR CELLS
    Laflamme, Vanessa
    Trottier, Jessica
    Pineault, Nicolas
    Vibhuti, Dave
    Roy, Denis-Claude
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (08) : S44 - S44
  • [22] Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells (vol 85, pg 415, 2006)
    Jang, Yun Kyung
    Jung, Dai Hyun
    Jung, Mee Hyun
    Kim, Dong Hyun
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    Oh, Wonil
    Yang, Yoon Sun
    Yang, Sung-Eun
    ANNALS OF HEMATOLOGY, 2006, 85 (05) : 343 - 344
  • [23] CD133-expressing cells with high aldehyde dehydrogenase activity represent a primitive human hematopoietic stem cell population with enhanced repopulating potential.
    Hess, DA
    Wirthlin, L
    Craft, TP
    Meyerrose, TE
    Nolta, JA
    BLOOD, 2004, 104 (11) : 75A - 75A
  • [24] RETENTION OF QUIESCENT HEMATOPOIETIC-CELLS WITH HIGH PROLIFERATIVE POTENTIAL DURING EX-VIVO STEM-CELL CULTURE
    YOUNG, J
    VARMA, A
    BACKER, M
    BLOOD, 1994, 84 (10) : A126 - A126
  • [25] Differentiation potential and cell cycle regulation of ex vivo expanded bone marrow-derived stem and progenitor cells for use in autologous cell therapy
    Goltry, K. L.
    Parrish, C.
    Pavlic, R. J.
    Hock, J. M.
    CYTOTHERAPY, 2006, 8
  • [26] Assessment of Short-Term Engraftment Potential of Ex Vivo Expanded Hematopoietic Stem Cells Using Normal Fetal Mouse in Utero Transplantation Model
    Zarrabi, Morteza
    Afzal, Elaheh
    Asghari, Mohammad Hassan
    Ebrahimi, Marzieh
    CELL JOURNAL, 2019, 21 (03) : 259 - 267
  • [27] A Comprehensive High Resolution Scrna-Seq Analytical Platform for Characterizing Human Hematopoietic Stem/Progenitor Cells States in Ex Vivo Drug Products
    Baricordi, Cristina
    Loperfido, Mariana
    Yan, Aimin
    Barbarossa, Luigi
    Segura, Mercedes
    Golipour, Azadeh
    Mason, Chris
    Biasco, Luca
    BLOOD, 2020, 136
  • [28] Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential
    Zheng, YZ
    Watanabe, N
    Nagamura-Inoue, T
    Igura, K
    Nagayama, H
    Tojo, A
    Tanosaki, R
    Takaue, Y
    Okamoto, S
    Takahashi, TA
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (12) : 1237 - 1246
  • [29] In vitro and in vivo evidence for the long-term multilineage (myeloid, lymphoid B, NK, T and dendritic) reconstitution capacity of ex vivo expanded human CD34+cord blood cells.
    Douay, L
    Kobari, L
    Pflumio, F
    Li, XX
    Giarratana, MC
    Titeux, M
    Izac, B
    Leteurtre, F
    Coulombel, L
    BLOOD, 2000, 96 (11) : 839A - 839A
  • [30] Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias
    Ciurea, Stefan O.
    Lee, Dean A.
    Cao, Kai
    Rondon, Gabriela
    Chen, Julianne
    Willis, Dana B.
    Ahmed, Sairah
    Yvon, Eric
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Champlin, Richard E.
    BLOOD, 2015, 126 (23)
12345